Psychometric Validation of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) in Patients With Spinocerebellar Ataxia
The Cerebellum · 12.06.2024 · 23 (5) · 2095-2108
DOI: 10.1007/s12311-024-01707-9 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift The Cerebellum, online erschienen am 12.06.2024. Verfasst von Michele Potashman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biohaven Pharmaceuticals, Inc, 215 Church Street, New Haven, CT, 06510, USA. Michele.potashman@biohavenpharma.com. Hauptthemen laut MEDLINE: Psychometrics, Spinocerebellar Ataxias. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biohaven Pharmaceuticals, Inc.
Abstract (Originalsprache)
This study aimed to generate evidence to support psychometric validity of the modified functional Scale for the Assessment and Rating of Ataxia (f-SARA) among patients with spinocerebellar ataxia (SCA). Psychometric measurement properties and minimal change thresholds of the f-SARA were evaluated using data from a cohort of SCA subjects (recruited at Massachusetts General Hospital [MGH]; n = 33) and data from a phase 3 trial of troriluzole in adults with SCA (NCT03701399 [Study 206]; n = 217), including a subset of patients with the SCA3 genotype ( n = 89). f-SARA item ceiling effects were absent within the MGH cohort, while floor effects were present. Excellent internal consistency reliability was demonstrated (α total = 0.90; α items-removed = 0.86–0.90), and item-to-total correlations were strong ( r = 0.82–0.91, per item). High test–retest reliability was demonstrated with intraclass correlation coefficients of 0.91 (total) and 0.73–0.92 (items). Convergent and divergent validity was supported, with strong correlations observed between the f-SARA and similarly constructed scales (FARS-FUNC, BARS, PROM-ADL, and FARS-ADL; all p < 0.001) and weaker correlations observed among measures of differing constructs. Mean item and total scores increased with disease severity (by FARS-FUNC quartile; p < 0.001). A 1-point threshold for meaningful changes was supported as 0.5 × SD = 0.89, SEM = 1.12, and mean changes from baseline for patients classified as “improved,” “no change,” or “deteriorated” were −0.68, 0.02, and 0.58, respectively. Similar trends were observed in Study 206 all-SCA and SCA3 cohorts. The measurement properties of the f-SARA provide evidence of its psychometric validity, responsiveness, and suitability as a clinical outcome measure in patients with SCA, including those with SCA3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biohaven Pharmaceuticals, Inc, 215 Church Street, New Haven, CT, 06510, USA. Michele.potashman@biohavenpharma.com.
- Broadstreet Health Economics & Outcomes Research, Vancouver, BC, Canada.
- Biohaven Pharmaceuticals, Inc, 215 Church Street, New Haven, CT, 06510, USA.
- Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Förderung
- Biohaven Pharmaceuticals, Inc
Zitieren
APA
Potashman, M., Popoff, E., Powell, L., Mackenzie, A., Beiner, M. W., Coric, V., Schmahmann, J., & L'Italien, G. (2024). Psychometric Validation of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) in Patients With Spinocerebellar Ataxia. The Cerebellum, 23(5), 2095-2108. https://doi.org/10.1007/s12311-024-01707-9
Vancouver
Potashman M, Popoff E, Powell L, Mackenzie A, Beiner MW, Coric V, et al. Psychometric Validation of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) in Patients With Spinocerebellar Ataxia. The Cerebellum. 2024;23(5):2095-2108. doi:10.1007/s12311-024-01707-9
BibTeX
@article{Potashman2024,
author = {Potashman, Michele and Popoff, Evan and Powell, Lauren and Mackenzie, Ainsley and Beiner, Melissa Wolfe and Coric, Vlad and Schmahmann, Jeremy and L'Italien, Gilbert},
title = {Psychometric Validation of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) in Patients With Spinocerebellar Ataxia},
journal = {The Cerebellum},
year = {2024},
volume = {23},
number = {5},
pages = {2095--2108},
doi = {10.1007/s12311-024-01707-9}
}
EUVIMED